Jasper Therapeutics, Inc.
JSPR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $311,827 | $82,364 | $17,620 | $89,412 |
| - Cash | $71,637 | $86,887 | $38,250 | $84,701 |
| + Debt | $1,813 | $2,786 | $3,651 | $2,885 |
| Enterprise Value | $242,003 | -$1,737 | -$16,979 | $7,596 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$74,866 | -$67,753 | -$50,221 | -$36,456 |
| % Margin | – | – | – | – |
| Net Income | -$71,269 | -$64,465 | -$37,685 | -$30,637 |
| % Margin | – | – | – | – |
| EPS Diluted | -4.89 | -6.18 | -10.33 | -26.89 |
| % Growth | 20.9% | 40.2% | 61.6% | – |
| Operating Cash Flow | -$62,602 | -$52,067 | -$45,858 | -$33,678 |
| Capital Expenditures | -$552 | -$267 | -$576 | -$2,428 |
| Free Cash Flow | -$63,154 | -$52,334 | -$46,434 | -$36,106 |